A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole [7]

Clinical and Experimental Dermatology

Volumn 32, Issue 3, 2007, Pages 327-328

  Roche, M ^a   Daly, P ^a   Crowley, V ^a   Darby, C ^a   Barnes, L ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DOCETAXEL;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; B CELL LYMPHOMA; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CASE REPORT; CELLULITIS; DEBRIDEMENT; DISEASE SEVERITY; FEMALE; FINGER AMPUTATION; HUMAN; HYPERTRICHOSIS; LABORATORY TEST; LETTER; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REMISSION; SKIN FRAGILITY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; FINGERS; HAND DERMATOSES; HUMANS; LYMPHOMA, B-CELL; MIDDLE AGED; NITRILES; PORPHYRIA CUTANEA TARDA; TREATMENT OUTCOME; TRIAZOLES;

EID: 33947645343     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02332.x     Document Type: Letter

References (3)

1. Byrne JP, Boss JM, Dawber RP. Contraceptive pill-induced porphyria cutanea tarda presenting with onycholysis of the finger nails. Postgrad Med J 1976; 52: 535-8.
2. Sarkany RPE. The management of porphyria cutanea tarda. Clin Exp Dermatol 2001; 26: 225-32.
3. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003; 348: 2431-42.